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Background:  Previous studies have suggested an obesity paradox in patients with coronary artery disease. Because obese patients are 
also known to have multiple metabolic derangements, therefore, we aimed to investigate the impact of obesity and it’s relation with metabolic 
parameters on clinical outcomes in patient undergoing percutaneous coronary intervention (PCI).
methods:  A total of 714 consecutive patients who underwent PCI between May 2010 and April 2011 were enrolled and divided into three groups 
according to body mass index (BMI): normal weight (BMI < 23.0 kg/m2, n=211), overweight (23.0 ≤ BMI < 27.5 kg/m2, n=375), and obese groups 
(BMI ≥ 27.5 kg/m2, n=128). Lipid profile, fasting glucose, insulin, HbA1c, and insulin sensitivity evaluated by quantitative insulin-sensitivity check 
index (QUICKI) were measured. Primary endpoint was 1-year major adverse cardiovascular events (MACEs), defined as the composite of all-cause 
death, non-fatal myocardial infarction (MI), stroke, revascularization, or admission for heart failure.
results:  The overweight or obese group had a higher incidence of hypertension, diabetes, and hyperlipidemia than the normal weight group. Left 
ventricular systolic dysfunction (ejection fraction < 40%) was more frequent in the normal group compared to the overweight or obese group (14.1% 
vs. 7.3% vs. 8.6%, p=0.026, respectively). Fasting glucose, HbA1c, LDL-cholesterol did not differ significantly between groups. However, obese group 
had higher levels of fasting insulin than normal weight group (12.5±13.6μU/mL vs. 8.6±12.4μU/mL, p=0.007). In addition, there was a significant 
difference of QUICKI between normal, overweight and obese groups (0.345±0.048 vs. 0.336±0.040 vs. 0.321±0.038, p<0.05 for each groups, 
respectively). The cumulative incidence of MACEs at 1 year was 15.6% for the normal group, 5.9% for the overweight group, and 3.9% for the obese 
group (p<0.001).
conclusions:  Overweight or obese patients had better clinical outcomes compared with normal weight patients after PCI although overweight or 
obese patients have more metabolic abnormality. 
